Infervision

Active#5 worldwide · Imaging & medical AINot open to Backers

Estimated valuation · Imaging & medical AI · China

Develops AI software that reads CT, X-ray and other scans to detect lung nodules, fractures, stroke and other conditions for hospitals in China and abroad.

Healthtech›Imaging & medical AI global.infervision.com

HQChina

Last roundSeries D · Jul 2021

Estimated valuation

AI · Imaging & medical AI ranking (worldwide)

≈ USD 720MUSD 360M–1.4bn · Hundreds of M$

Hundreds of k$

Millions $

Tens of M$

Hundreds of M$

Unicorn

Decacorn

Hectocorn

Anchor: Last known equity round: Series D · USD 139M · Jul 2021

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Uback rankings

How the AI ranks →

Ranking	Tier	Rank	Edition	Next update
Imaging & medical AI · worldwide	Top 25	#5	Edition 0 · Oct 2026	26 Apr 2027

Rank historyOct 2026 · #5 Imaging & medical AIFirst edition: no movements yet.

Funding history

Date	Round	Amount	Type	Investors
Jul 2021	Series D	USD 139M	Equity	Goldman Sachs, Z-Park Fund, CCB Trust

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Infervision as a PDF. It must answer at least one of these four questions, and stick to them:

AI valuation: $720MUndervalued or overvalued?

Versus competitorsHow does it compare?

Who should acquire itStrategic buyers, and why

Who should it acquireAcquisition targets, and why

Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Invest

Not open to BackersCompanies based in mainland China are ranked like any other startup, but Uback does not open pools on them: capital controls and offshore (VIE) structures make minority deals impractical for our Backers.

You can still declare an interest in this segment:

Or back imaging & medical ai worldwide

Do you run Infervision?

Claim this profile to correct data, add your logo and description, or tell Uback about an upcoming round.

Claim this profile Report an upcoming round → Report an error →

Are you a shareholder?

Considering selling some of your shares? Tell Uback privately. Nothing is published without your consent, and never a price or a volume.

Tell Uback privately

What the AI reads

Read by the AI at the next edition.

Comparable companies in imaging & medical ai

Full imaging & medical ai ranking →

Aidoc#4IsraelHundreds of M$Prenuvo#6United StatesHundreds of M$PathAI#3United StatesHundreds of M$Harrison.ai#7AustraliaHundreds of M$

Last updated: Oct 2026Report an error

Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.